Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Aims: Emergency departments (EDs) provide an opportunity to identify people at risk of overdose and reduce the risk. We evaluated the effect of an ED behavioral intervention delivered by peer recovery support specialists (PRSSs) on non-fatal opioid overdose.

Design: Two-arm, randomized trial.

Setting: Two EDs in Rhode Island, USA.

Participants: ED patients presenting with an opioid overdose, complications of opioid use disorder or a recent history of opioid overdose (November 2018-May 2021). Among 648 participants, the mean age was 36.9 years, 68.2% were male and 68.5% were White.

Intervention And Comparator: Participants were randomized to receive a behavioral intervention from a PRSS (n = 323) or a licensed clinical social worker (LICSW) (n = 325). PRSS and LICSW used evidence-based interviewing and intervention techniques, informed by their lived experience (PRSS) or clinical theory and practice (LICSW).

Measurements: We identified non-fatal opioid overdoses in the 18 months following the ED visit through linkage to statewide emergency medical services data using a validated case definition. The primary outcome was any non-fatal opioid overdose during the 18-month follow-up period.

Findings: Among 323 participants randomized to the PRSS arm, 81 (25.1%) had a non-fatal opioid overdose during follow-up, compared with 95 (29.2%) of 325 participants randomized to the LICSW arm (P = 0.24). There was no statistically significant difference in the effectiveness of randomization to the PRSS arm versus the LICSW arm on the risk of non-fatal opioid overdose, adjusting for the history of previous overdose (relative risk = 0.86, 95% confidence interval = 0.67-1.11).

Conclusions: In Rhode Island, USA, over one-in-four emergency department patients at high risk of overdose experience a non-fatal opioid overdose in the 18 months post-discharge. We found no evidence that the risk of non-fatal opioid overdose differs for emergency department patients receiving a behavioral intervention from a peer recovery support specialist versus a licensed clinical social worker.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568958PMC
http://dx.doi.org/10.1111/add.16581DOI Listing

Publication Analysis

Top Keywords

non-fatal opioid
32
opioid overdose
32
behavioral intervention
16
emergency department
12
participants randomized
12
opioid
11
overdose
11
non-fatal
8
overdose 18-month
8
risk overdose
8

Similar Publications

Background: American Indian and Alaska Native (AI/AN) communities experienced a disproportionate increase in opioid-related fatal and non-fatal poisonings during the COVID-19 pandemic. Access to treatment, such as medications for opioid use disorder (MOUD), became even more critical, although research among this population is limited. We completed qualitative interviews with substance use disorder (SUD) treatment providers (i.

View Article and Find Full Text PDF

Introduction: Non-prescribed use of opioid agonist treatment (OAT) medications is a public health concern. This study analyses the prevalence of non-prescribed use and non-fatal overdoses in Norway in 2013 and 2023, a period marked by an increasingly flexible OAT regimen, and examines associations between non-prescribed use and non-fatal overdoses.

Methods: Cross-sectional surveys with two convenience samples (n1=611 in 2013, n2=523 in 2023) of street-recruited individuals, who reported recent use of opioids and/or stimulants but were not currently enrolled in OAT, were employed.

View Article and Find Full Text PDF

Background: Opioid overdose is a significant public health problem among injectable drug users (IDUs), with non-fatal overdoses being a strong predictor of fatal overdoses. This study aimed to evaluate the burden, risk factors, and awareness related to non-fatal overdose among IDUs in Kolkata, India.

Methods: This cross-sectional study was conducted from September 2023 to March 2025 at two opioid substitution therapy centers and two government hospitals in Kolkata.

View Article and Find Full Text PDF

Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland.

Int J Drug Policy

July 2025

Bristol Medical School, University of Bristol, Bristol, United Kingdom; Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Canada. Electronic address: adeli

Introduction: In Scotland, co-use of opioids and benzodiazepines has been strongly linked to rising drug-related deaths, but little similar information is available for the rest of the UK. We compared characteristics of people who inject opioids (PWIO) by benzodiazepine use and examined its association with non-fatal overdose in England, Wales and Northern Ireland.

Methods: PWIO in England, Wales and Northern Ireland were recruited through specialist drug services in 2022 as part of the Unlinked Anonymous Monitoring Survey.

View Article and Find Full Text PDF

Introduction: As the opioid crisis continues, people who use drugs (PWUD) experience a disproportionate burden of both HIV and overdose, driven by increased injection-related HIV outbreaks and an opaque and rapidly evolving drug market, respectively. Pre-exposure prophylaxis (PrEP) for HIV and point-of-care drug checking services are underused yet potentially impactful interventions to address the harms of the opioid crisis. Implementing such interventions using known strategies to enhance client engagement and reduce access barriers, such as street outreach, mobile services and peer navigation, can optimise intervention and maximise their impact.

View Article and Find Full Text PDF